| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 44 | 2023 | 994 | 3.920 |
Why?
|
| Body Composition | 42 | 2022 | 596 | 3.310 |
Why?
|
| Water | 15 | 2022 | 364 | 3.080 |
Why?
|
| Deuterium | 18 | 2022 | 111 | 2.410 |
Why?
|
| Isoflavones | 7 | 2013 | 73 | 2.270 |
Why?
|
| Adipose Tissue | 18 | 2022 | 766 | 2.190 |
Why?
|
| Oxygen Isotopes | 15 | 2022 | 36 | 1.970 |
Why?
|
| Self Concept | 4 | 2016 | 212 | 1.610 |
Why?
|
| Obesity | 17 | 2023 | 2893 | 1.450 |
Why?
|
| Health Expenditures | 2 | 2023 | 211 | 1.440 |
Why?
|
| Body Water | 21 | 2018 | 132 | 1.430 |
Why?
|
| Exercise | 14 | 2023 | 1186 | 1.420 |
Why?
|
| Body Weight | 20 | 2021 | 1292 | 1.360 |
Why?
|
| Body Mass Index | 20 | 2018 | 2213 | 1.220 |
Why?
|
| Menopause | 3 | 2013 | 159 | 1.210 |
Why?
|
| beta-Glucans | 3 | 2013 | 34 | 1.170 |
Why?
|
| Dietary Supplements | 7 | 2021 | 563 | 1.090 |
Why?
|
| Hepatitis C, Chronic | 2 | 2021 | 451 | 1.090 |
Why?
|
| Energy Intake | 17 | 2021 | 518 | 1.040 |
Why?
|
| Minority Groups | 5 | 2017 | 318 | 0.950 |
Why?
|
| Postmenopause | 3 | 2010 | 377 | 0.940 |
Why?
|
| Health Care Costs | 4 | 2023 | 677 | 0.910 |
Why?
|
| Weight Reduction Programs | 3 | 2016 | 78 | 0.910 |
Why?
|
| Weight Loss | 7 | 2018 | 629 | 0.860 |
Why?
|
| Camping | 3 | 2016 | 16 | 0.840 |
Why?
|
| Diet | 8 | 2019 | 1451 | 0.770 |
Why?
|
| Liver Cirrhosis | 2 | 2021 | 943 | 0.750 |
Why?
|
| Absorptiometry, Photon | 8 | 2022 | 241 | 0.740 |
Why?
|
| Bone Density | 6 | 2009 | 472 | 0.690 |
Why?
|
| Plant Extracts | 2 | 2012 | 224 | 0.690 |
Why?
|
| Deuterium Oxide | 5 | 2015 | 20 | 0.680 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2018 | 10 | 0.670 |
Why?
|
| Quality of Life | 3 | 2023 | 4578 | 0.660 |
Why?
|
| Basal Metabolism | 11 | 2023 | 88 | 0.650 |
Why?
|
| Indicator Dilution Techniques | 4 | 2022 | 22 | 0.640 |
Why?
|
| Dementia | 1 | 2023 | 454 | 0.630 |
Why?
|
| Mass Spectrometry | 8 | 2015 | 702 | 0.620 |
Why?
|
| Diet, Carbohydrate-Restricted | 4 | 2020 | 20 | 0.620 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2023 | 235 | 0.620 |
Why?
|
| Isotope Labeling | 8 | 2022 | 142 | 0.620 |
Why?
|
| Hydrogen | 6 | 2012 | 57 | 0.600 |
Why?
|
| Milk, Human | 7 | 2015 | 277 | 0.590 |
Why?
|
| Infant Nutritional Physiological Phenomena | 4 | 2015 | 182 | 0.570 |
Why?
|
| Female | 100 | 2023 | 142232 | 0.570 |
Why?
|
| Ontario | 5 | 2023 | 97 | 0.560 |
Why?
|
| Breast Feeding | 6 | 2019 | 241 | 0.550 |
Why?
|
| Anthropometry | 5 | 2015 | 269 | 0.540 |
Why?
|
| Community Health Services | 2 | 2016 | 128 | 0.520 |
Why?
|
| Urinalysis | 1 | 2015 | 84 | 0.520 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 29 | 0.520 |
Why?
|
| Diet, Reducing | 2 | 2020 | 87 | 0.520 |
Why?
|
| Overweight | 6 | 2018 | 487 | 0.510 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 4330 | 0.510 |
Why?
|
| Kidney Failure, Chronic | 3 | 2013 | 967 | 0.510 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 2028 | 0.510 |
Why?
|
| Cost of Illness | 2 | 2021 | 502 | 0.500 |
Why?
|
| Humans | 131 | 2023 | 262184 | 0.500 |
Why?
|
| Sleep | 3 | 2016 | 414 | 0.490 |
Why?
|
| Male | 73 | 2023 | 123269 | 0.490 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2011 | 37 | 0.480 |
Why?
|
| Health Promotion | 2 | 2016 | 501 | 0.470 |
Why?
|
| Young Adult | 23 | 2023 | 21473 | 0.460 |
Why?
|
| Adult | 64 | 2023 | 78082 | 0.450 |
Why?
|
| Nephrotic Syndrome | 1 | 2013 | 61 | 0.450 |
Why?
|
| Adolescent | 30 | 2023 | 31247 | 0.440 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2012 | 101 | 0.420 |
Why?
|
| Child | 28 | 2022 | 29125 | 0.420 |
Why?
|
| Nutritional Status | 2 | 2015 | 339 | 0.400 |
Why?
|
| Phytoestrogens | 2 | 2010 | 26 | 0.400 |
Why?
|
| Hepatitis B, Chronic | 1 | 2013 | 137 | 0.400 |
Why?
|
| Peritoneal Dialysis | 2 | 2012 | 125 | 0.390 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 146 | 0.390 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 95 | 0.380 |
Why?
|
| Antiviral Agents | 2 | 2021 | 1232 | 0.380 |
Why?
|
| Nutritional Requirements | 7 | 2018 | 185 | 0.380 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4563 | 0.370 |
Why?
|
| Reproducibility of Results | 13 | 2017 | 6038 | 0.370 |
Why?
|
| Child Nutritional Physiological Phenomena | 3 | 2016 | 174 | 0.360 |
Why?
|
| Child, Preschool | 19 | 2022 | 16249 | 0.360 |
Why?
|
| Blood Pressure | 3 | 2017 | 1465 | 0.350 |
Why?
|
| Liver Transplantation | 2 | 2021 | 1105 | 0.350 |
Why?
|
| Middle Aged | 36 | 2022 | 86445 | 0.350 |
Why?
|
| Vitamin B Complex | 1 | 2009 | 51 | 0.340 |
Why?
|
| Behavior Therapy | 1 | 2012 | 295 | 0.340 |
Why?
|
| Adiposity | 3 | 2021 | 238 | 0.330 |
Why?
|
| Infant | 22 | 2022 | 13297 | 0.320 |
Why?
|
| Nitric Oxide | 1 | 2012 | 644 | 0.320 |
Why?
|
| Pregnancy, Twin | 2 | 2018 | 118 | 0.310 |
Why?
|
| Infant, Newborn | 25 | 2022 | 8224 | 0.310 |
Why?
|
| Models, Biological | 13 | 2014 | 3249 | 0.300 |
Why?
|
| Program Evaluation | 6 | 2016 | 602 | 0.300 |
Why?
|
| Extracellular Space | 3 | 2000 | 131 | 0.300 |
Why?
|
| Self Report | 5 | 2018 | 766 | 0.290 |
Why?
|
| Sex Factors | 6 | 2017 | 2156 | 0.290 |
Why?
|
| Canada | 2 | 2021 | 431 | 0.290 |
Why?
|
| Dietary Proteins | 5 | 2015 | 241 | 0.280 |
Why?
|
| Placebos | 4 | 2013 | 441 | 0.280 |
Why?
|
| Bromides | 2 | 2000 | 4 | 0.280 |
Why?
|
| Double-Blind Method | 5 | 2013 | 2597 | 0.270 |
Why?
|
| Cohort Studies | 8 | 2022 | 9294 | 0.270 |
Why?
|
| Puberty | 2 | 2023 | 104 | 0.270 |
Why?
|
| Diet Surveys | 2 | 2016 | 118 | 0.260 |
Why?
|
| Hepatitis C | 2 | 2021 | 525 | 0.240 |
Why?
|
| Plethysmography | 3 | 2012 | 31 | 0.240 |
Why?
|
| Proteins | 6 | 2018 | 1954 | 0.240 |
Why?
|
| Urine | 3 | 2012 | 143 | 0.240 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2003 | 3 | 0.240 |
Why?
|
| Calibration | 3 | 2022 | 337 | 0.230 |
Why?
|
| Life Style | 2 | 2022 | 615 | 0.230 |
Why?
|
| School Health Services | 2 | 2016 | 109 | 0.230 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 5713 | 0.230 |
Why?
|
| Transients and Migrants | 1 | 2003 | 27 | 0.230 |
Why?
|
| Infant, Premature | 5 | 2012 | 791 | 0.230 |
Why?
|
| Dietary Carbohydrates | 3 | 2020 | 135 | 0.220 |
Why?
|
| Mammography | 1 | 2009 | 1010 | 0.220 |
Why?
|
| Drinking | 1 | 2022 | 54 | 0.220 |
Why?
|
| Breast | 2 | 2009 | 1350 | 0.220 |
Why?
|
| Motor Activity | 5 | 2014 | 693 | 0.220 |
Why?
|
| Membrane Proteins | 1 | 2013 | 2815 | 0.220 |
Why?
|
| Health Services | 1 | 2023 | 109 | 0.210 |
Why?
|
| Birth Weight | 4 | 2018 | 372 | 0.210 |
Why?
|
| Pregnancy | 15 | 2022 | 7551 | 0.210 |
Why?
|
| Hypocotyl | 2 | 2012 | 5 | 0.210 |
Why?
|
| Heart Failure, Systolic | 1 | 2022 | 31 | 0.210 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 36 | 0.210 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 1341 | 0.200 |
Why?
|
| Poverty | 2 | 2016 | 472 | 0.200 |
Why?
|
| Aged | 20 | 2022 | 70323 | 0.200 |
Why?
|
| Malnutrition | 2 | 2021 | 219 | 0.190 |
Why?
|
| Lasers | 1 | 2022 | 197 | 0.190 |
Why?
|
| Sexual Behavior | 1 | 2023 | 309 | 0.190 |
Why?
|
| Urban Population | 4 | 2014 | 269 | 0.190 |
Why?
|
| Body Fluid Compartments | 2 | 2018 | 21 | 0.190 |
Why?
|
| Eating | 2 | 2017 | 423 | 0.190 |
Why?
|
| Residence Characteristics | 2 | 2014 | 349 | 0.190 |
Why?
|
| Regression Analysis | 6 | 2016 | 1550 | 0.190 |
Why?
|
| Income | 1 | 2021 | 225 | 0.190 |
Why?
|
| Plasma Volume | 1 | 2000 | 16 | 0.190 |
Why?
|
| Pediatric Obesity | 2 | 2016 | 365 | 0.180 |
Why?
|
| Accelerometry | 3 | 2018 | 63 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1229 | 0.180 |
Why?
|
| Women's Health | 2 | 2012 | 206 | 0.180 |
Why?
|
| Longitudinal Studies | 7 | 2022 | 1947 | 0.180 |
Why?
|
| Health Resources | 1 | 2021 | 168 | 0.180 |
Why?
|
| Breeding | 1 | 1999 | 29 | 0.180 |
Why?
|
| Water Supply | 1 | 2019 | 24 | 0.180 |
Why?
|
| Nutritive Value | 2 | 2012 | 96 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2019 | 68 | 0.180 |
Why?
|
| International Agencies | 1 | 2019 | 107 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1999 | 60 | 0.170 |
Why?
|
| Survivors | 2 | 2015 | 1035 | 0.170 |
Why?
|
| Minerals | 2 | 1998 | 71 | 0.170 |
Why?
|
| Sheep | 1 | 1999 | 258 | 0.170 |
Why?
|
| Age Factors | 5 | 2018 | 5385 | 0.170 |
Why?
|
| Literature, Modern | 1 | 2018 | 8 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 948 | 0.170 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 49 | 0.170 |
Why?
|
| Ovariectomy | 1 | 2000 | 330 | 0.160 |
Why?
|
| Hepacivirus | 1 | 2021 | 398 | 0.160 |
Why?
|
| Weight Gain | 7 | 2022 | 464 | 0.160 |
Why?
|
| Texas | 4 | 2014 | 6308 | 0.160 |
Why?
|
| Insulin | 3 | 2018 | 1447 | 0.160 |
Why?
|
| Body Height | 2 | 2018 | 231 | 0.160 |
Why?
|
| Linear Models | 6 | 2016 | 1090 | 0.160 |
Why?
|
| Phantoms, Imaging | 1 | 2004 | 1275 | 0.160 |
Why?
|
| Hospitals | 1 | 2021 | 490 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 2205 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 29997 | 0.150 |
Why?
|
| Potassium, Dietary | 1 | 2017 | 12 | 0.150 |
Why?
|
| Social Class | 2 | 2022 | 311 | 0.150 |
Why?
|
| Sodium, Dietary | 1 | 2017 | 34 | 0.150 |
Why?
|
| Fetal Development | 1 | 2018 | 119 | 0.150 |
Why?
|
| Mass Screening | 2 | 2018 | 1505 | 0.150 |
Why?
|
| Cholesterol | 3 | 1995 | 657 | 0.150 |
Why?
|
| Health Education | 3 | 2009 | 309 | 0.150 |
Why?
|
| Skinfold Thickness | 2 | 2015 | 39 | 0.150 |
Why?
|
| Reproduction | 3 | 2023 | 252 | 0.140 |
Why?
|
| Sugars | 1 | 2016 | 15 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2017 | 88 | 0.140 |
Why?
|
| Heart Failure | 2 | 2022 | 2523 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1999 | 625 | 0.140 |
Why?
|
| Photography | 1 | 2017 | 138 | 0.140 |
Why?
|
| Aging | 2 | 2022 | 1538 | 0.140 |
Why?
|
| Carbon Dioxide | 11 | 1994 | 317 | 0.140 |
Why?
|
| Dietary Sucrose | 1 | 2016 | 43 | 0.140 |
Why?
|
| Food | 3 | 2017 | 146 | 0.140 |
Why?
|
| Biological Availability | 2 | 2011 | 224 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2022 | 2234 | 0.140 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2000 | 81 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2018 | 575 | 0.140 |
Why?
|
| Seasons | 2 | 2013 | 340 | 0.140 |
Why?
|
| United States | 5 | 2023 | 15561 | 0.140 |
Why?
|
| Nitrogen | 2 | 2015 | 164 | 0.130 |
Why?
|
| Calorimetry, Indirect | 4 | 2021 | 60 | 0.130 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 35 | 0.130 |
Why?
|
| Soybean Proteins | 2 | 2011 | 20 | 0.130 |
Why?
|
| Sri Lanka | 1 | 2015 | 8 | 0.130 |
Why?
|
| Caregivers | 1 | 2021 | 678 | 0.130 |
Why?
|
| Salvage Therapy | 1 | 2004 | 2056 | 0.130 |
Why?
|
| Child Health Services | 1 | 2016 | 82 | 0.130 |
Why?
|
| Risk Factors | 6 | 2018 | 17606 | 0.130 |
Why?
|
| Analysis of Variance | 6 | 2004 | 2310 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 187 | 0.120 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 25 | 0.120 |
Why?
|
| Prevalence | 3 | 2018 | 3271 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 867 | 0.120 |
Why?
|
| Pandemics | 1 | 2023 | 1567 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 360 | 0.120 |
Why?
|
| New Zealand | 1 | 2013 | 60 | 0.120 |
Why?
|
| Founder Effect | 1 | 2013 | 42 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 109 | 0.110 |
Why?
|
| British Columbia | 2 | 2023 | 24 | 0.110 |
Why?
|
| Mutation | 1 | 2013 | 15185 | 0.110 |
Why?
|
| Heart Rate | 3 | 2014 | 736 | 0.110 |
Why?
|
| Gases | 1 | 2012 | 36 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 1173 | 0.110 |
Why?
|
| Cats | 1 | 2012 | 166 | 0.110 |
Why?
|
| Markov Chains | 1 | 2013 | 175 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 56 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 1995 | 260 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 227 | 0.110 |
Why?
|
| Catalysis | 1 | 2012 | 249 | 0.100 |
Why?
|
| Platinum | 1 | 2012 | 139 | 0.100 |
Why?
|
| Models, Statistical | 2 | 2018 | 1177 | 0.100 |
Why?
|
| Infant Food | 5 | 2007 | 89 | 0.100 |
Why?
|
| Renal Replacement Therapy | 1 | 2013 | 136 | 0.100 |
Why?
|
| Equol | 1 | 2011 | 4 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2023 | 38006 | 0.100 |
Why?
|
| Zinc | 1 | 2012 | 190 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 10067 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 15706 | 0.100 |
Why?
|
| Tritium | 1 | 1991 | 197 | 0.100 |
Why?
|
| Physical Fitness | 2 | 2009 | 125 | 0.100 |
Why?
|
| Lactation | 4 | 1997 | 210 | 0.090 |
Why?
|
| Thiamine | 1 | 2009 | 11 | 0.090 |
Why?
|
| Electric Conductivity | 4 | 2002 | 94 | 0.090 |
Why?
|
| Riboflavin | 1 | 2009 | 26 | 0.090 |
Why?
|
| Animals | 11 | 2022 | 59506 | 0.090 |
Why?
|
| Endometrium | 1 | 2013 | 469 | 0.090 |
Why?
|
| Vitamin B 12 | 1 | 2009 | 73 | 0.090 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 239 | 0.080 |
Why?
|
| Gestational Age | 4 | 2018 | 1064 | 0.080 |
Why?
|
| Carbon Isotopes | 5 | 1996 | 332 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2022 | 416 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2012 | 1392 | 0.080 |
Why?
|
| Time Factors | 4 | 2013 | 12969 | 0.080 |
Why?
|
| Oxygen | 2 | 1999 | 754 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 14902 | 0.080 |
Why?
|
| Phenotype | 2 | 2023 | 6265 | 0.080 |
Why?
|
| Lactose | 2 | 2005 | 63 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2018 | 32986 | 0.080 |
Why?
|
| Urban Health Services | 1 | 2007 | 37 | 0.080 |
Why?
|
| Prospective Studies | 7 | 2021 | 12914 | 0.070 |
Why?
|
| Vitamin D | 1 | 2009 | 261 | 0.070 |
Why?
|
| Risk | 1 | 2012 | 1972 | 0.070 |
Why?
|
| Guanidines | 1 | 1987 | 60 | 0.070 |
Why?
|
| Mathematics | 7 | 2003 | 135 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 5777 | 0.070 |
Why?
|
| Bias | 2 | 2015 | 206 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 1987 | 118 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 601 | 0.070 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2006 | 26 | 0.070 |
Why?
|
| Gastric Emptying | 1 | 2006 | 94 | 0.070 |
Why?
|
| Electroacupuncture | 1 | 2006 | 35 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 1866 | 0.070 |
Why?
|
| Reference Values | 3 | 2018 | 1098 | 0.070 |
Why?
|
| Saliva | 1 | 1987 | 230 | 0.070 |
Why?
|
| Body Fluids | 1 | 1987 | 125 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 4321 | 0.070 |
Why?
|
| Carbon | 2 | 1985 | 150 | 0.070 |
Why?
|
| HIV Antibodies | 1 | 2006 | 102 | 0.070 |
Why?
|
| Cognition | 1 | 2012 | 975 | 0.070 |
Why?
|
| Homosexuality, Male | 1 | 2005 | 71 | 0.070 |
Why?
|
| Electric Impedance | 4 | 2001 | 101 | 0.060 |
Why?
|
| Lactase | 1 | 2005 | 38 | 0.060 |
Why?
|
| Syphilis | 1 | 2005 | 61 | 0.060 |
Why?
|
| Health Behavior | 1 | 2009 | 602 | 0.060 |
Why?
|
| Indians, North American | 2 | 1997 | 87 | 0.060 |
Why?
|
| Incidence | 2 | 2012 | 5709 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2006 | 220 | 0.060 |
Why?
|
| Leptin | 3 | 2015 | 295 | 0.060 |
Why?
|
| Bicarbonates | 6 | 1991 | 131 | 0.060 |
Why?
|
| Femur Neck | 1 | 2004 | 23 | 0.060 |
Why?
|
| Radiodermatitis | 1 | 2004 | 76 | 0.060 |
Why?
|
| Postpartum Period | 3 | 2018 | 259 | 0.060 |
Why?
|
| San Francisco | 1 | 2003 | 20 | 0.060 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2023 | 30 | 0.060 |
Why?
|
| Hip Joint | 1 | 2004 | 59 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2006 | 666 | 0.060 |
Why?
|
| Femur | 1 | 2004 | 157 | 0.060 |
Why?
|
| Actigraphy | 2 | 2014 | 54 | 0.060 |
Why?
|
| Swine | 3 | 1993 | 1553 | 0.060 |
Why?
|
| Calcium | 1 | 2009 | 1548 | 0.060 |
Why?
|
| Humidity | 1 | 2022 | 29 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 416 | 0.050 |
Why?
|
| Calorimetry | 3 | 1994 | 62 | 0.050 |
Why?
|
| Thinness | 1 | 2003 | 82 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2004 | 247 | 0.050 |
Why?
|
| Research Design | 2 | 2022 | 1562 | 0.050 |
Why?
|
| Spine | 1 | 2004 | 294 | 0.050 |
Why?
|
| Disease Progression | 1 | 2013 | 6696 | 0.050 |
Why?
|
| Sierra Leone | 1 | 2021 | 28 | 0.050 |
Why?
|
| Prognosis | 3 | 2015 | 21745 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 2327 | 0.050 |
Why?
|
| Oxygen Consumption | 4 | 2010 | 398 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 4944 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2022 | 139 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2007 | 1215 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 647 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7728 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 364 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2006 | 619 | 0.050 |
Why?
|
| Biomarkers | 3 | 2017 | 5052 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2000 | 125 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2004 | 999 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 3023 | 0.040 |
Why?
|
| Overnutrition | 1 | 2019 | 15 | 0.040 |
Why?
|
| Health Personnel | 1 | 2005 | 631 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5540 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 1999 | 57 | 0.040 |
Why?
|
| Sexual Behavior, Animal | 1 | 1999 | 65 | 0.040 |
Why?
|
| Animal Feed | 1 | 1999 | 80 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1999 | 275 | 0.040 |
Why?
|
| Prostatectomy | 1 | 2004 | 963 | 0.040 |
Why?
|
| Growth | 1 | 1999 | 117 | 0.040 |
Why?
|
| Dietary Fats | 2 | 2017 | 342 | 0.040 |
Why?
|
| Neoplasms | 2 | 2015 | 15201 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 1999 | 351 | 0.040 |
Why?
|
| Kinetics | 6 | 1995 | 2040 | 0.040 |
Why?
|
| Software | 2 | 2004 | 1325 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2005 | 1083 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 74 | 0.040 |
Why?
|
| Breath Tests | 7 | 1991 | 175 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2011 | 6892 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 91 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 1999 | 660 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2022 | 1276 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 52 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2018 | 41 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 124 | 0.040 |
Why?
|
| Hunger | 1 | 2017 | 47 | 0.040 |
Why?
|
| Physical Examination | 1 | 1999 | 299 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2004 | 927 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 1032 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2017 | 1836 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2012 | 444 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2017 | 92 | 0.040 |
Why?
|
| Medical Records | 2 | 2012 | 414 | 0.040 |
Why?
|
| Mammaplasty | 1 | 2004 | 780 | 0.040 |
Why?
|
| Time | 1 | 2017 | 179 | 0.040 |
Why?
|
| Torso | 1 | 2017 | 73 | 0.040 |
Why?
|
| Lysine | 2 | 1991 | 423 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2023 | 947 | 0.030 |
Why?
|
| Body Size | 1 | 2016 | 70 | 0.030 |
Why?
|
| Acceleration | 2 | 2012 | 32 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 4978 | 0.030 |
Why?
|
| Fructose | 1 | 2016 | 72 | 0.030 |
Why?
|
| Longevity | 1 | 2017 | 150 | 0.030 |
Why?
|
| Boston | 1 | 2015 | 108 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 21 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 421 | 0.030 |
Why?
|
| Absorption | 1 | 1995 | 80 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 411 | 0.030 |
Why?
|
| Ergometry | 1 | 1994 | 5 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 26 | 0.030 |
Why?
|
| Intestinal Absorption | 5 | 2005 | 215 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2015 | 2802 | 0.030 |
Why?
|
| Blood Glucose | 1 | 1999 | 1242 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 641 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 96 | 0.030 |
Why?
|
| Maintenance Chemotherapy | 1 | 2015 | 203 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 170 | 0.030 |
Why?
|
| Cholesterol, HDL | 2 | 2012 | 342 | 0.030 |
Why?
|
| Physical Exertion | 2 | 2010 | 113 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 78 | 0.030 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1994 | 32 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 63 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 644 | 0.030 |
Why?
|
| Erythrocytes | 1 | 1995 | 339 | 0.030 |
Why?
|
| HIV Infections | 1 | 2006 | 2132 | 0.030 |
Why?
|
| Potassium | 2 | 2007 | 330 | 0.030 |
Why?
|
| Triglycerides | 2 | 2012 | 604 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 1993 | 189 | 0.030 |
Why?
|
| Lactation Disorders | 1 | 1992 | 8 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2012 | 29 | 0.030 |
Why?
|
| Rats | 2 | 2000 | 6109 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 65 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 1995 | 256 | 0.030 |
Why?
|
| Chemistry | 1 | 1991 | 99 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1991 | 137 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2012 | 389 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 462 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 1992 | 299 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 773 | 0.020 |
Why?
|
| Anions | 1 | 1989 | 39 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 1989 | 67 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 2632 | 0.020 |
Why?
|
| Wakefulness | 1 | 2010 | 150 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 3576 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2014 | 779 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 354 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2012 | 6105 | 0.020 |
Why?
|
| Equipment Design | 2 | 2006 | 1207 | 0.020 |
Why?
|
| Administration, Oral | 3 | 2006 | 1556 | 0.020 |
Why?
|
| Flour | 1 | 2007 | 7 | 0.020 |
Why?
|
| Microchemistry | 1 | 1987 | 11 | 0.020 |
Why?
|
| Guanidine | 1 | 1987 | 12 | 0.020 |
Why?
|
| Oxygen Radioisotopes | 1 | 1987 | 6 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 58 | 0.020 |
Why?
|
| Zea mays | 1 | 2007 | 46 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1984 | 418 | 0.020 |
Why?
|
| Food, Fortified | 1 | 2007 | 95 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 106 | 0.020 |
Why?
|
| Bottle Feeding | 1 | 2006 | 36 | 0.020 |
Why?
|
| Glucans | 1 | 1986 | 18 | 0.020 |
Why?
|
| Dextropropoxyphene | 1 | 2006 | 7 | 0.020 |
Why?
|
| HIV Seroprevalence | 1 | 2006 | 11 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2012 | 730 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2006 | 203 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2006 | 32 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1985 | 33 | 0.020 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2006 | 59 | 0.020 |
Why?
|
| Malawi | 1 | 2007 | 385 | 0.020 |
Why?
|
| Infant Formula | 1 | 2006 | 91 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1985 | 128 | 0.020 |
Why?
|
| California | 1 | 2006 | 208 | 0.020 |
Why?
|
| Fatty Acids, Volatile | 1 | 1985 | 52 | 0.020 |
Why?
|
| Narcotics | 1 | 2006 | 123 | 0.020 |
Why?
|
| Aminopyrine | 1 | 1985 | 5 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1989 | 1328 | 0.020 |
Why?
|
| Lactose Intolerance | 1 | 2005 | 11 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2006 | 116 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 5008 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 306 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2005 | 75 | 0.020 |
Why?
|
| Digestion | 1 | 2005 | 55 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 127 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 2187 | 0.020 |
Why?
|
| Morphine | 1 | 2006 | 308 | 0.020 |
Why?
|
| Intestine, Small | 2 | 2005 | 499 | 0.020 |
Why?
|
| Methods | 1 | 2003 | 189 | 0.010 |
Why?
|
| Perfusion | 1 | 2005 | 294 | 0.010 |
Why?
|
| Edible Grain | 1 | 1983 | 55 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2007 | 613 | 0.010 |
Why?
|
| Feces | 2 | 1983 | 772 | 0.010 |
Why?
|
| Glucose | 2 | 1986 | 1246 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 667 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2006 | 983 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8883 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 10009 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 2006 | 832 | 0.010 |
Why?
|
| Paracoccus denitrificans | 1 | 1999 | 1 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 2424 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 2233 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12236 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 1259 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 784 | 0.010 |
Why?
|
| Mastectomy | 1 | 2004 | 1538 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2004 | 3846 | 0.010 |
Why?
|
| Child Development | 1 | 1997 | 255 | 0.010 |
Why?
|
| Rest | 1 | 1994 | 70 | 0.010 |
Why?
|
| Leucine | 1 | 1996 | 352 | 0.010 |
Why?
|
| Sodium Bicarbonate | 2 | 1985 | 59 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 1994 | 54 | 0.010 |
Why?
|
| Plant Preparations | 1 | 1994 | 36 | 0.010 |
Why?
|
| Weaning | 1 | 1993 | 47 | 0.010 |
Why?
|
| Exercise Test | 1 | 1994 | 306 | 0.010 |
Why?
|
| Milk | 1 | 1994 | 120 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1986 | 719 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14300 | 0.010 |
Why?
|
| Body Constitution | 1 | 1992 | 35 | 0.010 |
Why?
|
| Mexico | 1 | 1992 | 257 | 0.010 |
Why?
|
| Respiration | 2 | 1984 | 447 | 0.010 |
Why?
|
| Estrogens | 1 | 1994 | 748 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1988 | 46 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 5339 | 0.010 |
Why?
|
| Electromagnetic Phenomena | 1 | 1986 | 18 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1986 | 110 | 0.000 |
Why?
|
| Half-Life | 1 | 1986 | 258 | 0.000 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1985 | 41 | 0.000 |
Why?
|
| Genotype | 1 | 1993 | 4108 | 0.000 |
Why?
|
| Acetates | 1 | 1985 | 105 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 191 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1986 | 935 | 0.000 |
Why?
|
| Nutrition Disorders | 1 | 1984 | 57 | 0.000 |
Why?
|
| Rabbits | 1 | 1985 | 960 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 705 | 0.000 |
Why?
|
| Sodium | 1 | 1985 | 353 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 11575 | 0.000 |
Why?
|
| Rectum | 1 | 1985 | 468 | 0.000 |
Why?
|
| Colon | 1 | 1983 | 673 | 0.000 |
Why?
|
| Liver | 1 | 1985 | 2904 | 0.000 |
Why?
|